| scholarly article | Q13442814 |
| P2093 | author name string | Li Chen | |
| Wenbo Qi | |||
| Juan Xu | |||
| Feng Yue | |||
| Jingbo Wang | |||
| P2860 | cites work | NF-κB p50 and p52 Regulate Receptor Activator of NF-κB Ligand (RANKL) and Tumor Necrosis Factor-induced Osteoclast Precursor Differentiation by Activating c-Fos and NFATc1 | Q57675122 |
| Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation | Q57675158 | ||
| Genetic control of skeletal development | Q58326890 | ||
| c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling | Q58326943 | ||
| Bone and haematopoietic defects in mice lacking c-fos | Q58326969 | ||
| Tetracycline administration normalizes the structure and acid phosphatase activity of osteoclasts in streptozotocin-induced diabetic rats | Q68475031 | ||
| v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation | Q79383955 | ||
| Hyperglycemia Impairs Skeletogenesis from Embryonic Stem Cells by Affecting Osteoblast and Osteoclast Differentiation | Q85183080 | ||
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families | Q28137631 | ||
| Bone resorption by osteoclasts | Q28145169 | ||
| Disorders of Bone Remodeling | Q28295303 | ||
| DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells | Q28506839 | ||
| OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
| Role of DC-STAMP in cellular fusion of osteoclasts and macrophage giant cells | Q28589731 | ||
| Osteoclast differentiation and activation | Q29547556 | ||
| Genetic regulation of osteoclast development and function | Q29617421 | ||
| Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts | Q29618116 | ||
| Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies | Q36028626 | ||
| Fos/AP-1 proteins in bone and the immune system | Q36324940 | ||
| Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis | Q36636165 | ||
| The molecular understanding of osteoclast differentiation | Q36650749 | ||
| Are nonresorbing osteoclasts sources of bone anabolic activity? | Q36709511 | ||
| Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture | Q36851830 | ||
| Diabetes and fractures: an overshadowed association | Q37102803 | ||
| NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). | Q37302319 | ||
| Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos | Q38342636 | ||
| Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator | Q38363724 | ||
| High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesis | Q39996770 | ||
| Prevalence and control of diabetes in Chinese adults | Q40134909 | ||
| Purification of RNA using TRIzol (TRI reagent). | Q43048322 | ||
| Curcumin suppresses increased bone resorption by inhibiting osteoclastogenesis in rats with streptozotocin-induced diabetes | Q43287788 | ||
| Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus | Q43739331 | ||
| The effects of systemic insulin, insulin-like growth factor-I and growth hormone on bone growth and turnover in spontaneously diabetic BB rats | Q43918360 | ||
| Serum levels of bone resorption markers are decreased in patients with type 2 diabetes | Q44094049 | ||
| Tissue mineralization is increased following 1-year treatment with high doses of bisphosphonates in dogs | Q44695650 | ||
| Inhibitory effects of high glucose/insulin environment on osteoclast formation and resorption in vitro | Q45021787 | ||
| Thioredoxin-1 overexpression in transgenic mice attenuates streptozotocin-induced diabetic osteopenia: a novel role of oxidative stress and therapeutic implications. | Q46161156 | ||
| Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral density | Q46462609 | ||
| Microdamage accumulation in the monkey vertebra does not occur when bone turnover is suppressed by 50% or less with estrogen or raloxifene | Q46571677 | ||
| Bone formation in spontaneously diabetic Torii-newly established model of non-obese type 2 diabetes rats. | Q46883073 | ||
| The effects of local platelet rich plasma delivery on diabetic fracture healing. | Q51301204 | ||
| Histomorphometric analysis of diabetic osteopenia in streptozotocin-induced diabetic mice: a possible role of oxidative stress. | Q53575266 | ||
| Induction of DC-STAMP by Alternative Activation and Downstream Signaling Mechanisms | Q57675118 | ||
| P433 | issue | 2 | |
| P921 | main subject | transmembrane protein | Q424204 |
| dendritic cell | Q506253 | ||
| P304 | page(s) | 865-870 | |
| P577 | publication date | 2014-10-29 | |
| P1433 | published in | Molecular Medicine Reports | Q26842180 |
| P1476 | title | High glucose inhibits receptor activator of nuclear factor‑κB ligand-induced osteoclast differentiation via downregulation of v‑ATPase V0 subunit d2 and dendritic cell‑specific transmembrane protein | |
| P478 | volume | 11 |
| Q38939772 | A new perspective on mechanisms governing skeletal complications in type 1 diabetes |
| Q42504968 | High glucose alters the secretome of mechanically stimulated osteocyte-like cells affecting osteoclast precursor recruitment and differentiation. |
| Q35234933 | MicroRNA-22 impairs anti-tumor ability of dendritic cells by targeting p38. |
| Q38888332 | N-acetylglucosamine suppresses osteoclastogenesis in part through the promotion of O-GlcNAcylation. |
| Q90218092 | Osteoclasts in bone regeneration under type 2 diabetes mellitus |
| Q39127683 | Pathophysiology of Bone Fragility in Patients with Diabetes. |
| Q58725004 | Skeletal Fragility in Type 2 Diabetes Mellitus |
| Q33766770 | Succinate and its G-protein-coupled receptor stimulates osteoclastogenesis. |
| Q58795849 | Type 2 diabetes affects bone cells precursors and bone turnover |
| Q64230394 | Update on the impact of type 2 diabetes mellitus on bone metabolism and material properties |
Search more.